Total Funding
38
15
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
380543
Neoprospecta uses high-throughput genomic sequencing and large scale bioinformatics.
Luiz Oliveira: CEOPast Role: Neoprospecta, CBO
About the Company
Neoprospecta, a contract research company, uses high-throughput genomic sequencing and large scale bioinformatics to find new genes, enzymes, and other proteins from the biodiversity. It specializes in bioprospecting of new enzymes, peptides, and other proteins.
Neoprospecta offers custom metagenomic bioprospection, contract research, enzyme
development, and conservation biology services. Luiz Fernando Valter de Oliveira, Luiz Felipe Valter de Oliveira, Ronaldo Mota, and Marcos Carvalho founded it on January 21, 2011, with its headquarters in Florianópolis in Brazil.
